This article provides a detailed comparative analysis of linked-read exome sequencing (LR-WES) and standard whole-exome sequencing (WES) for detecting structural variants (SVs), a critical but historically challenging class of genomic...
This article provides a comprehensive comparison of L1 (Lasso) and L-infinity penalty functions for researchers and drug development professionals.
This article provides a comprehensive resource for researchers performing RNA-seq analysis, detailing the theory, application, and optimization of the Kallisto and Salmon tools for transcript-level quantification.
This comprehensive guide demystifies the entire RNA sequencing (RNA-seq) workflow for biomedical researchers and drug development professionals.
This article provides a comprehensive guide for researchers and drug development professionals on integrating Copy Number Variation (CNV) analysis with Whole Exome Sequencing (WES) Variant of Uncertain Significance (VUS) interpretation.
This comprehensive guide explores the critical role of in-silico annotation tools—CADD, PolyPhen-2, and SIFT—in prioritizing Variants of Uncertain Significance (VUS) for researchers and drug development professionals.
This article provides a comprehensive review of evidence-based strategies to enhance the diagnostic yield of Whole Exome Sequencing (WES) in the investigation of congenital anomalies.
This comprehensive guide provides researchers, scientists, and drug development professionals with a complete workflow for performing RNA-seq read alignment using the STAR (Spliced Transcripts Alignment to a Reference) aligner.
This comprehensive guide provides researchers, scientists, and drug development professionals with a complete workflow for generating gene count matrices from BAM alignment files, a critical step in RNA-seq and other...
This definitive guide clarifies the critical choice between traditional alignment (e.g., STAR, HISAT2) and pseudoalignment (e.g., kallisto, salmon) for RNA-seq analysis.